key: cord-0770032-y5flzxfh authors: Willaert, Ronnie G.; Kayacan, Yeseren; Devreese, Bart title: The Flo Adhesin Family date: 2021-10-28 journal: Pathogens DOI: 10.3390/pathogens10111397 sha: 9a679d0e57d6666c7b505fb48caf7212f5f10455 doc_id: 770032 cord_uid: y5flzxfh The first step in the infection of fungal pathogens in humans is the adhesion of the pathogen to host tissue cells or abiotic surfaces such as catheters and implants. One of the main players involved in this are the expressed cell wall adhesins. Here, we review the Flo adhesin family and their involvement in the adhesion of these yeasts during human infections. Firstly, we redefined the Flo adhesin family based on the domain architectures that are present in the Flo adhesins and their functions, and set up a new classification of Flo adhesins. Next, the structure, function, and adhesion mechanisms of the Flo adhesins whose structure has been solved are discussed in detail. Finally, we identified from Pfam database datamining yeasts that could express Flo adhesins and are encountered in human infections and their adhesin architectures. These yeasts are discussed in relation to their adhesion characteristics and involvement in infections. Fungal infections are an extremely important growing health problem since they kill over 1.6 million people worldwide per year [1] [2] [3] . Fungi are present everywhere in our environment and are, usually, harmless for healthy people. Fungal infections can be topical and local, such as surface infections on the skin or in the vaginal tract. Systemic infections arise when the fungi enter and proliferate in the bloodstream. Systemic fungal infections affect people with an altered immune system due to medical interventions, i.e., cancer therapy, organ transplantation, asthma and the use of immune-modulatory medications, immunosuppressive diseases (such as Acquired Immune Deficiency Syndrome (AIDS)) [4] , or malnutrition (under-and overnutrition) [5] [6] [7] . In addition, viral pneumonia increases patients' susceptibility to fungal superinfections. During the recent COVID-19 pandemic, COVID-19-associated pulmonary aspergillosis was responsible for a substantial increased mortality [8] [9] [10] [11] [12] . The contribution of fungal infections to the global burden of disease is largely unrecognised [1, [13] [14] [15] . It is estimated that around 1.7 billion people have superficial fungal infections such as skin, hair and nail infections [1, 15, 16] . Mucosal fungal infections of the oral and genital tracts are also an extremely burden, especially vulvovaginal candidiasis. It was estimated that around 50 to 75% of women in their childbearing years suffer from at least one episode of vulvovaginitis, and 5 to 8% (around 75 million women) have at least four episodes annually [15, 17] . Recent global estimates have found 3,000,000 cases of chronic pulmonary aspergillosis,~223,100 cases of cryptococcal meningitis complicating HIV/AIDS,~700,000 cases of invasive candidiasis,~500,000 cases of Pneumocystis jirovecii The member proteins of the adhesin family have a modular configuration that consists of three domains (N-terminal, central and C-terminal domain) and an amino-terminal secretory sequence that must be removed when the protein moves to the plasma membrane through the secretory pathway [35, 49, 85, 86] . The GPI anchor is modified as the proteins become linked to β-1,6-glucan in the wall. Despite the intensive research on yeast adhesion, a relative low number of adhesin structures have been investigated at the molecular level and their structure solved [86] (Table 1) . The adhesins that belong to this type, contain a PA14 domain (Pfam family PA14, PF07691) or a GLEYA domain (Pfam family GLEYA, PF10528) in the N-terminal part of the adhesin. The PA14 domain family was discovered based on the sequence analysis of an insert in bacterial β-glucosidases, which was also found in other glycosidases, glycosyltransferases, proteases, amidases, yeast adhesins, and bacterial toxins [87] . The insert is a 14-kDa region of PA20, which is a fragment of the protective antigen (PA) from anthrax toxin, has a β-barrel structure [88] . The PA14 domain is present in 2448 species, 974 protein architectures, and in 54 solved protein structures (Pfam 34.0, March 2021). The presence of a calcium-dependent carbohydrate-binding pocket is a common element in the PA14 domain family [89, 90] . The GLEYA domain is structurally related to lectin-like binding domains found in fungal adhesins such as the S. cerevisiae Flo proteins and the C. glabrata Epa proteins [91] . The distinction is not always clear as can be noted from the Uniprot description of the adhesins containing a GLEYA domain (Table 1 ). An EYDGA pentapeptide motif belonging to the PA14 domain was identified [92] and was found to be present in the N-terminal domain of Epa1 from C. glabrata, where it is involved in carbohydrate binding. This motif is comparable to the VSWGT pentapeptide in Flo1p from S. cerevisiae [91] . The VSWGT motif of Flo1p and the EYDGA motif are present in the same position The member proteins of the adhesin family have a modular configuration that consists of three domains (N-terminal, central and C-terminal domain) and an amino-terminal secretory sequence that must be removed when the protein moves to the plasma membrane through the secretory pathway [35, 49, 85, 86] . The GPI anchor is modified as the proteins become linked to β-1,6-glucan in the wall. Despite the intensive research on yeast adhesion, a relative low number of adhesin structures have been investigated at the molecular level and their structure solved [86] (Table 1) . The adhesins that belong to this type, contain a PA14 domain (Pfam family PA14, PF07691) or a GLEYA domain (Pfam family GLEYA, PF10528) in the N-terminal part of the adhesin. The PA14 domain family was discovered based on the sequence analysis of an insert in bacterial β-glucosidases, which was also found in other glycosidases, glycosyltransferases, proteases, amidases, yeast adhesins, and bacterial toxins [87] . The insert is a 14-kDa region of PA 20 , which is a fragment of the protective antigen (PA) from anthrax toxin, has a β-barrel structure [88] . The PA14 domain is present in 2448 species, 974 protein architectures, and in 54 solved protein structures (Pfam 34.0, March 2021). The presence of a calcium-dependent carbohydrate-binding pocket is a common element in the PA14 domain family [89, 90] . The GLEYA domain is structurally related to lectin-like binding domains found in fungal adhesins such as the S. cerevisiae Flo proteins and the C. glabrata Epa proteins [91] . The distinction is not always clear as can be noted from the Uniprot description of the adhesins containing a GLEYA domain (Table 1 ). An EYDGA pentapeptide motif belonging to the PA14 domain was identified [92] and was found to be present in the N-terminal domain of Epa1 from C. glabrata, where it is involved in carbohydrate binding. This motif is comparable to the VSWGT pentapeptide in Flo1p from S. cerevisiae [91] . The VSWGT motif of Flo1p and the EYDGA motif are present in the same position within a hypervariable region of the PA14 domain [93] . The VSWGT/KVLAR motif of Flo1p/Lg-Flo1p and the EYDGA motif of Epa1p represent a surface loop between Pathogens 2021, 10, 1397 5 of 39 two β-strands, 9 and 10, in the structure of the anthrax toxin PA domain [88] . Adhesins with a GLEYA domain possess a typical N-terminal signal peptide and a domain of conserved sequence repeats but lack GPI anchor attachment signals [91] . However, it was demonstrated for Epa1 that the GPI anchor is essential both for cross-linking in the cell wall and for Epa1-mediated adherence [45, 94] . The GLEYA domain contains a conserved motif G(M/L)(E/A/N/Q)YA, hence the name GLEYA. Based on sequence homology, it was suggested that the GLEYA domain would predominantly contain β-sheets, which was later confirmed by the solved structures of Epa1p and Epa9p (Table 1) [92, 95] . Several of the N-terminal adhesion domains of the PA14 type Flo proteins were solved (Table 1) , i.e., N-Flo5p [100] and N-Flo1p from S. cerevisiae [93] (Figure 2A) , and N-Lg-Flo1p from S. pastorianus [93, 96] . The atomic structures of N-Flo1p, N-Lg-Flo1p, N-Flo5p, N-Epa1p, N-Epa6p, and N-Epa9p are very similar ( Figure 2 ). The main body of these proteins, i.e., the PA14/GLEYA domain, is a β-sandwich fold made up of two antiparallel β-sheets and an L-shaped region composed of the N and C-terminal regions (Figure 2A,B) . N-Flo1p and N-Flo5p contain a protruding β-sheet subdomain (the Flo1/Flo5 subdomain) that is located at one end of the protein, close to the carbohydrate binding site ( Figure 2A1 ). In Lg-Flo1p and N-Epa1, this subdomain is replaced by a short highly flexible loop 2 [95, 96, 99] . The high flexible loop 3 (L3) is present in N-Flo1p and N-Lg-Flo1 (Figure 2A ), as well as in N-Flo5p and N-Epa1 ( Figure 2B ); and has a significant effect on carbohydrate recognition. In contrast to N-Flo5p, this loop of N-Flo1p is closer to the binding side and lysine 194 (K194) from this loop interacts directly with the carbohydrate, which results in a three-fold increase in affinity for mannose compared to N-Flo5p. In Epa1p, the L3 loop establishes stronger stacking interactions with the ligands galactose and galactose-terminating glycans via tryptophan 194 (W194) (which corresponds to K194 in Flo1p) [92, 95] . The carbohydrate-binding pocket of N-Lg-Flo1p is more enclosed than the one of N-Flo1p, which results in a 10 times higher affinity for the ligand mannose [93] . Mannose disaccharides and high-mannose glycans fit differently in the binding sites of N-Flo1p and N-Flo5p, which results in a different specificities and affinities. Longer mannose-containing oligosaccharides do not interact well with N-Lg-Flo1p due to the steric hindrance encountered in the binding site. The binding site of these proteins contains a calcium ion that is directly involved in carbohydrate binding ( Figure 2 ). In N-Flo1p and N-Flo5p, Ca 2+ is coordinated on carbohydrate binding loop 1 by cis peptides aspartic acid 160 (D160) and D161 (indicated as "DcisD" motif) ( Figure 2A1 ), and on CBL2 by the asparagine 224 (N224) side chain and the carbonyl groups of valine 226 (V226) and W228. These residues are strongly conserved in the Flo and Epa adhesin families due to their importance for metal binding ( Figure 2A3 ,B3) [95, 100] . Flocculation cell-cell binding in floc or biofilm formation is based on the lectin function of the PA14/GLEYA Flo type adhesins. N-Flo1p and N-Flo5p binds specifically to D-mannose glycans [93, 100, 101] . The affinity for these lectins is around 10 times larger than for monosaccharides [86] . N-Lg-Flo1p displays a broader specificity towards sugars [93, 96] . Expressed PA14/GLEYA Flo type adhesins are the dominant cell wall proteins that stick out of the cell wall [102] . On flocculating cells, N-Flo1p interacts homophilically with the glycans of N-Flo1p of the interacting cell in the presence of Ca 2+ [93] . In addition, it was demonstrated that glycan-glycan interactions with the involvement of Ca 2+ interactions contribute to cell-cell interactions [93] , and that these interactions are likely involved in the first intercellular contacts [103, 104] . These results pointed to a two-step cell-cell adhesion mechanism, where in the first step the long, flexible glycans have a high probability of interaction when the cells are moving close to each other and initially serve to stabilize cell-cell interactions. In the next step, the non-reducing glycan end enter the binding pocket of the lectin and binds to the protein. In both steps, Ca 2+ is crucial for the interactions. tions contribute to cell-cell interactions [93] , and that these interactions are likely involved in the first intercellular contacts [103, 104] . These results pointed to a two-step cell-cell adhesion mechanism, where in the first step the long, flexible glycans have a high probability of interaction when the cells are moving close to each other and initially serve to stabilize cell-cell interactions. In the next step, the non-reducing glycan end enter the binding pocket of the lectin and binds to the protein. In both steps, Ca 2+ is crucial for the interactions. Structure of the N-terminal part of Flo1p (from PDB entry 4LHN). The "DcisD" motif is indicated in black by the residues Asp160 and Asp161. 2. Mannose-binding pocket surface zoomed view (top left), electrostatic surface (top right), hydrophobic (brown)-hydrophilic (cyan blue) surface (bottom left), conserved amino acids coloured surface (bottom right). 3. Colouring of the structure by sequence conservation; low to high conservation: from blue (−1.8) to white to red (1.9) (calculated via the ConSurf server [105, 106] Colouring of the structure by sequence conservation; low to high conservation: from blue (−1.8) to white to red (1.9) (calculated via the ConSurf server [105, 106] It has been recently discovered that amyloid-like bonds can contribute to C. albicans cell-cell interactions via the Als adhesins [107] [108] [109] . These intercellular bonds show properties of cross-β aggregation and in addition to the interactions that cluster the adhesins on yeast cell surfaces [110] . Data on Flo1p also support the formation of cross-β bonds in trans between expressing cells [109] . The N-Flo1p domain is followed by a variable number of Pathogens 2021, 10, 1397 9 of 39 tandem repeats that are predicted to have anti-parallel β-sheet structure, and these repeats unfold under extension or shear force [110, 111] . The expression of the S. cerevisiae flocculation protein Flo11p can play a role in lifestyles involving complex multicellular structures such as flocs, filaments, mats, and flors a major role in these lifestyles, which give yeast selective advantages to survive in specific growth conditions [40, 64, 70, 112, 113] . When the carbon source (e.g., glucose) is depleted in the growth medium, FLO11 is expressed, which makes haploid S. cerevisiae cells adherent and allows them to invade into semi-solid agar medium; this is called "invasive growth" [44, 66, 114] . Diploid cells will adopt-when nitrogen becomes limiting in the growth medium-an elongated shape and form filaments that grow from the colony edge; this is called diploid pseudohyphal growth [44, [115] [116] [117] . Flo11p can also be involved in the formation of mats, which are complex colony-like structures on a low-density (0.3%) semi-solid medium (that resembles the environment of rotting fruit on which these yeasts can grow [118] ) [43, 71, 119, 120] ; the formation of a flor (or velum), which is the airliquid interfacial cellular aggregation in the process of wine (beer) fermentations [121] [122] [123] [124] . The adherence of cells to solid surfaces (such as glass, stainless steel, agar, and plastics) can also lead to the development of biofilms [43, 44, 125, 126] . Cell-cell interaction (floc formation) can also be based on Flo11p interaction [44, 49, 69, 72, 74, 75, 112, 127] . Many parameters influence the expression of FLO11 and flocculation activity such as the cell density, surface charge, and pH, and environmental factors such as oxygen limitation, nutrient limitation, and cell surface hydrophobicity [127] [128] [129] [130] . Flo11p mediates different processes in different strains [38, 66, 72, 74, 112, 127] , and strain-specific differences in the level of flocculation result from significant sequence differences in the FLO11 alleles, and do not depend on quantitative differences in FLO11 expression or surface hydrophobicity [131] . The structures of two N-terminal adhesion domains of Flo11p have been solved by using X-ray crystallography (Table 1) , i.e., the one of Flo11p from S. cerevisiae (N-ScFlo11p) [69] and recently the one from Komagataella pastoris (N-KpFlo11p) [99] . Despite a sequence identity between-N-KpFlo11p and N-ScFlo11p of only 32%, their overall structures showed a high degree of similarity after superposition [99] ( Figure 3B2 ). Three subdomains can be distinguished: a hydrophobic apical region, a β sandwich of the fibronectin type III domain (FN3-like domain), and the neck subdomain ( Figure 3A1 ,B1). The core domain is the β sandwich that is formed by the antiparallel β sheets I and II and was assigned to the class of fibronectin type-III-like domains (FNIII). This core domain showed the highest degree of similarity between the two N-Flo1p adhesin domains [99] , and this domain is well conserved ( Figure 3A3 ,B3). The FNIII fold forms a large family within the immunoglobulin (Ig) superfamily that includes cell adhesion proteins, cell surface hormone and cytokine receptors, chaperones, and carbohydrate-binding domains [132] . The FNIII-like domain subtype shows a seven-stranded strand-switched type, where sheet I consist of three strands and sheet II of four strands ( Figure 3A1 ,B1). The FNIII fold differs from other Ig folds by its fourth strand, which is part of the second, but not the first, β sheet [69] . The FNIII-like domain contains by two surface aromatic bands at the apical region and the neck subdomain ( Figure 3A2 ) [69, 99] . These aromatic bands are well conserved ( Figure 3A3 ,B3). Hydrophobic interactions between these aromatic surface features, whose propensity for interaction is ameliorated in a pH-dependent manner by co-distributed acidic residues ( Figure 3A2 ,A5), mostly determine the homophilic recognition by the Flo11 adhesin domains ( Figure 3A4 ). Even though these hydrophobic interactions are less specific than the lectin-carbohydrate interactions of the other Flo adhesins, they can excel by their long range of attractive forces. Single-cell force spectroscopy showed that these N-Flo11p domains confer remarkably strong adhesion forces between cells, leading to efficient cell aggregation and biofilm formation [99] . The co-alignment of Flo11 fibres from The FNIII-like domain contains by two surface aromatic bands at the apical region and the neck subdomain ( Figure 3A2 ) [69, 99] . These aromatic bands are well conserved ( Figure 3A3 ,B3). Hydrophobic interactions between these aromatic surface features, whose propensity for interaction is ameliorated in a pH-dependent manner by co-distributed acidic residues ( Figure 3A2 ,A5), mostly determine the homophilic recognition by the Flo11 adhesin domains ( Figure 3A4 ). Even though these hydrophobic interactions are less specific than the lectin-carbohydrate interactions of the other Flo adhesins, they can excel by their long range of attractive forces. Single-cell force spectroscopy showed that these N-Flo11p domains confer remarkably strong adhesion forces between cells, leading to efficient cell aggregation and biofilm formation [99] . The co-alignment of Flo11 fibres from opposing yeast cells could be observed by scanning electron microscopy, indicating that Flo11p acts as a spacer-like, pH-sensitive adhesin that resembles a membrane-tethered hydrophobin [69] . As for Flo1p, data on Flo11p also support the involvement of this adhesin in the formation of cross-β bonds in trans between cells [109] . There are potential amyloid core sequences in the post N-terminal domain and C-terminal regions [133] . As for Flo1 and Als adhesins, the ability to form cellular aggregates can be induced by shear force. 4.1. Pathogenic Candida Species 4.1.1. Candida glabrata C. glabrata strains were originally classified in the genus Cryptococcus and next Torulopsis due to its lack of filaments formation, and was in 1978 classified in the genus Candida due to it human pathogenicity [134, 135] . C. glabrata is more closely related to S. cerevisiae than to C. albicans [59, 134, [136] [137] [138] [139] . It is a major opportunistic human fungal pathogen that has become the second most frequent cause of Candida infections [134, [140] [141] [142] [143] . It is a nondimorphic yeast that exist as small blastoconidia under all environmental conditions as a pathogen (it does not form pseudohyphae at temperatures above 37 • C) [134] . C. glabrata can cause superficial and life-threatening dissemination infections reaching high mortalities of around 40% [144] . Immunocompromised, cancer and diabetic patients are particularly susceptible [18, 54, 142, [145] [146] [147] . C. glabrata shows a high antifungal resistance against azole antifungal agents [24] . It can adhere to host tissues cells as well as to abiotic surfaces and colonize them as biofilms, which further increase the antifungal resistance and evade the host immune defences [144, [148] [149] [150] [151] [152] . Biofilms on medical devices (e.g., indwelling catheters or prosthetic heart valves) can result in failure of the device and the cells in the biofilm can initiate future continuing infections [153] [154] [155] [156] [157] . C. glabrata can express many adhesin-encoding genes and genome comparisons with closely related species, including S. cerevisiae, revealed a correlation between the number of adhesin-encoding genes and pathogenicity [152, 158, 159] . The adhesins from the Epa ("epithelial adhesion") family are up-to-now the best characterised adhesins from C. glabrata; the structures of N-Epa1p [92, 95, 98] , N-Epa6p [98] , and N-Epa9p [98] have been solved recently [86] . These N-terminal Epa adhesin domains contain a GLEYA domain with lectin activity, which is Ca 2+ dependent, and recognizes a wide variety of glycans with terminal galactose residues linked via αor β-glycosidic bonds to a secondary sugar for conferring epithelial cell adhesion [53, 98] C. glabrata can also express Epa23p, which can be classified as a PA14/GLEYA-type flocculin since the adhesin architecture is composed of a PA14 domain and 5 flocculin repeat domains (Table 2 ). In the other members of the Epa family, such as Epa1p, Epa2p, Epa3p, Epa6p and Epa 9p, only the GLEYA domain is present in the N-terminal region of the adhesin. Epa adhesins mediate adherence to human epithelial and endothelial cells by recognizing glycans containing terminal galactose residues [47] and show the highest affinity for the Thomsen-Friedenreich (T or TF) antigen (Galβ-1,3-GalNAc), which likely mediates N-Epap adherence to highly glycosylated proteins such as mucins [95] . It was also demonstrated that N-Epa1p binds to fibronectin from human plasma [53, 160] as well as to mucin [53] . Many other human receptors of Epa adhesins have been predicted by constructing their lectin-glycan interaction (LGI) network, which is an approach that is based on linking glycan array screening results of the adhesins to a human glycoprotein database [53] . The Epa1p, Epa6p and Epa7p LGI network revealed that a large set of receptors are present in body fluids or displayed on human cells in various body systems; receptors included several mucins (urogetinal, respiratory, exocrine and digestive system), κ-casein (exocrine system), epidermal growth factor receptor (EGFR, urogenital system), cadherin-5 (CD144, urogenital system), lactotransferrin (LTF, exocrine system), serotransferrin (TF, hemic system), immunoglobulin M (IgM, hemic system), tumor necrosis factor alpha (TNFα, hemic system), P-selectin glycoprotein ligand (PSGL-1, hemic system), leukosialin (CD43, respiratory system), receptor-type tyrosine-protein phosphatase C (CD45, hemic system), von Willebrand factor (vWF, hemic system), β-secretase 1 (BACE1, urogenital system), lysosome-associated membrane glycoprotein 1 2 (LAMP1/2, hemic system), plasminogen (PLG, urogenital system). Clavispora lusitaniae, which is the teleomorph of C. lusitaniae, is an environmental saprophytic yeast that belongs to the CTG clade of Candida [161] (Table 2) . C. lusitaniae can behave rarely as an opportunistic pathogen in humans, and its most common risk factors include immunocompromised patients often with an underlying malignancy [162] . However, nosocomial acquisition secondary to an indwelling urinary catheter [163] , and catheterassociated C. lusitaniae candidemia [164] have also been reported. Amphotericin B resistance among isolates of C. lusitaniae has distinguished it among Candida species [165] . The adhesion of C. lusitaniae to abiotic surfaces (polystyrene and steel surfaces) has been demonstrated [166] . C. lusitaniae strains can express adhesins that contain an N-terminal GLEYA domain and a flocculin repeat domain (Table 2) , as well as adhesins that contain one or more N-terminal Flo11 domains and none or multiple flocculin type 3 repeats (Table 2) . It is expected that multiple Flo11 adhesin domains will increase the interaction strength. Currently, these adhesins have not been characterized at the molecular nor cellular level, and very little is known about their role in the adhesion process. Recently, it was shown that when the Flo11 domain from C. lusitaniae was expressed in an S. cerevisiae expression system, adhesive growth was conferred to S. cerevisiae [99] . C. parapsilosis can be isolated from domestic animals, insects, the soil and marine environments [167, 168] . C. parapsilosis (sensu lato) was reclassified as a fungal complex formed by three genotypically distinguishable species, i.e., C. parapsilosis (sensu stricto), C. orthopsilosis and C. metapsilosis [169] . The opportunistic yeast C. parapsilosis is responsible for 20-30% of all fungal infections, particularly those related to the usage of catheter and other medical devices, and it became the second most frequently opportunistic yeast isolated from bloodstream infections in different clinical settings around the world, especially in Latin America and Asia [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] . C. parapsilosis is associated with a pronounced capacity to adhere to plastic surfaces and several other implanted devices, and consequently to the development of candidaemia related to catheters [153, 183] . The adhesion of C. parapsilosis to polystyrene and steel surfaces has been demonstrated [166] . Pseudohyphal formation was also positively correlated with adhesion of C. parapsilosis complex strains abiotic surfaces, such as polystyrene and glass [183] , and acrylic surfaces [184] . Cell surface hydrophobicity can have a significant effect on the initial events leading to adherence [185] and it has been shown that it can make C. albicans and C. glabrata more virulent [186] . An elevated cell hydrophobicity has been recorded for clinical C. parapsilosis complex strains [183, 187] . C. tropicalis is a diploid dimorphic yeast, which lives either as budding cells or as a pseudomycelium; in rare cases it can form true hyphae (as for C. albicans) [188, 189] . It is taxonomically close to C. albicans and shares many pathogenic traits [190] . It is one of the three most commonly isolated non-albicans Candida species [168, [191] [192] [193] [194] [195] [196] [197] . It is mainly isolated from blood and urine samples [192, 198, 199] . It is also often detected in patients requiring prolonged catherization, receiving broad-spectrum antibiotics and with cancer [195, 198, [200] [201] [202] . In addition, C. tropicalis displayed a higher potential for dissemination in neurotropenic individuals compared to C. albicans and other non-albicans Candida species [195] . A bioinformatic search of pathogen-specific gene families of Candida species (C. parapsilosis, C. tropicalis, L. elongispora, C. guilliemondii) revealed several genes for putative cell wall adhesins-like proteins such as Als-like adhesins, Hyr/Iff proteins, and Pga30-like proteins (predicted glycosylphosphatidyl-inositol-anchored protein 30) [203, 204] . Genome data also allowed to identify five genes homologous to the ALS (agglutinin-like sequence) gene family of C. albicans in C. parapsilosis, three in C. orthopsilosis and four in C. metapsilosis [205] . Considerable variation was noted in relative gene expression for isolates of the same species. It was shown that the gene CpALS7 showed a positive correlation with adhesion to extracellular matrix proteins under fluid shear stress [206] . Site-specific deletion of CpALS7 reduced the adhesion of C. parapsilosis to buccal epithelial cells and significantly attenuated virulence in a murine model of urinary tract infection [207] . One C. parapsilosis Flo11-type adhesin and one in C. tropicalis were found in the Pfam database (Table 3 ). They both have the same protein architectures since besides the Flo11 domain they contain also two flocculin type 3 repeats. Their molecular characterization, virulence, and role of these adhesins in the adhesion process is currently not yet known and needs further investigation. These Flo11-type adhesions could play a role in biofilm formation since it was shown that C. parapsilosis and C. tropicalis displayed a high biofilm formation ability as well as a high adhesion ability [208] . [209] . It is an emerging multidrugresistant fungal pathogen of the Candida/Clavispora clade that is becoming a worldwide public health treat over the past decade due severe invasive infections with high mortality rates [210] [211] [212] [213] [214] . Due to its capability of nosocomial transmission and forming adherent biofilms on clinically important substrates, a high number of related hospital outbreaks have been reported worldwide [215] . Recently, genomic analyses revealed that early contemporaneously detected cases of C. auris were geographically stratified into four major clades [216] . While Clades I, III, and IV are responsible for ongoing outbreaks of invasive and multidrug-resistant infections, Clade II, also termed the East Asian clade, consists primarily of cases of ear infection, is often susceptible to all antifungal drugs, and has not been associated with outbreaks. The virulence factors associated with C. auris infections are not yet completely understood [217] . C. auris pathogenic attributes that have been identified include pathways required for cell wall modelling and nutrient acquisition, two-component systems, the production of hydrolytic enzymes such as phospholipases and proteinases that are likely involved in the adherence and invasion of host cells and tissues during infections, other mechanisms of tissue invasion, and immune evasion and multidrug efflux systems [217] [218] [219] [220] [221] [222] [223] . Other adhesin genes identified in C. auris include orthologs of C. albicans ALS genes such as ALS3 and ALS4, while Als3p was identified on C. auris cell surface by anti-C. albicans Als3p antibodies [218, 224] . Subtelomeric dynamics and the conservation of cell surface proteins (including Hyr/Iff-like and novel candidate cell wall proteins, and an Als-like adhesin) in the clades responsible for global outbreaks causing invasive infections suggest an explanation for the different phenotypes observed between clades [216] . C. auris can form biofilms on several indwelling medical devices, such as catheters, central/peripheral line tips, and neurological shunts [223, 225, 226] . Biofilm formation protects C. auris from triazoles, polyenes, and echinocandins antifungal drugs [227, 228] . It was shown. That seven adhesin genes (IFF4, CSA1, PGA26, PGA52, PGA7, HYR3 and ALS5) were upregulated during biofilm formation [227] . The GPI-anchored cell wall genes (IFF4, CSA1, PGA26, PGA52) were upregulated at all time points during in vitro biofilm formation, while HYR3 and ALS5 were only upregulated in mature biofilms [227, 229] . Additionally, key role genes involved in biofilm extracellular matrix formation, such as encoding efflux pumps (MDR and CDR homologs) and glucan-modifying enzymes, were upregulated during biofilm formation, and their inhibition improved the susceptibility of biofilms to fluconazole [228] [229] [230] . We found one Flo11 type adhesin in the Pfam database (Table 3 ). In addition to the N-terminal Flo11 domain, it contains a collagen triple helix repeat (Collagen (PF01391)) in the middle-C-terminal region of the protein. The collagen triple helix or type-2 helix is the primary secondary structure of various types of fibrous collagen, including type I collagen [231, 232] . It consists of a triple helix made of the repetitious amino acid sequence glycine-X-Y, where X and Y are frequently proline or hydroxyproline. This Collagen domain could mechanically stabilize the adhesin allowing it to stick out as a straight rod from the cell surface reaching for receptors/surfaces to interact with. As Flo11p in S. cerevisiae is involved in pseudohyphal growth, one suggestion is that this adhesin also plays a role in pseudohyphal-like aggregate formation in C. auris. These aggregates of pseudohyphal-like cells cannot be disrupted physically or chemically with detergents [223] . The ability to aggregate was shown to be an inducible trait since aggregate formation was stimulated by the prior exposure of C. auris to triazoles or echinocandins [233] . Aggregative phenotypes have been predominantly isolated from colonized patients and have higher capacity for biofilm formation than non-aggregative phenotypes [234, 235] . A study showed that aggregate formation may help C. auris to evade immune recognition and thus facilitate its persistence in tissues [225] . This contrasted with another study where mice survived a high-dose C. auris intravenous challenge, even after cyclophosphamide -induced immunosuppression, in C5 complement deficiency in A/J mice and mice deficient in neutrophil elastase [236] . These contrasting results are likely due to differences in virulence of the tested strains and/or the infection model [217] . Meyerozyma guilliermondii (anamorph C. guilliermondii) is an ascomycetous yeast, which is widely distributed in nature, the human skin and the mucosal microflora [237, 238] . Isolates identified as C. guilliermondii (teleomorph Pichia guilliermondii) were included in the new Meyerozyma genus by Kurtzman and Suzuki in 2010 [239] . The M. guilliermondii complex is a genetically heterogeneous complex comprising several phenotypically indistinguishable taxa, including M. guilliermondii, C. fermentati, C. carpophila, and C. xestobi [240] [241] [242] . With several unique characteristics and physiology, such as the wide substrates spectrum and capability of various chemicals synthesis, M. guilliermondii has been recognized for its biotechnological applications such as industrial enzyme production, metabolites synthesis and biocontrol capacity [243] . The incidence of human infections is low (ranges from 1 to 3% depending on the geographic region [244] [245] [246] ), but cases of candidemia (especially in patients with cancer), endocarditis and invasive disease have been reported and increased over the years [237, [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] . Despite the low incidence of candidaemia caused by this organism, M. guilliermondii is of particular clinical significance as it exhibits increased resistance to antifungal agents (azoles and echinocandins), compared to other Candida species [244, 264] . We found two Flo11-type M. guilliermondii adhesins in the Pfam database: in one strain the protein contained only the Flo11 domain whereas in the other strain an additional flocculin type 3 repeat was present. These Flo11-type adhesins could play a role in surface adhesion and biofilm formation since it was demonstrated that M. guilliermondii has a high adhesion ability (comparable to the ones of C. tropicalis and C. parapsilosis) as well as a high biofilm formation ability [208] . Recently, the N-terminal region (containing the Flo11 domain) of a Flo11-type adhesin from M. guilliermondii was introduced into an S. cerevisiae expression system based on the S. cerevisiae Flo11p and allowing the presentation of the adhesin domain at the cell surface for functional analysis [99] . It was shown that the Flo11 domain from M. guilliermondii was competent to confer adhesive growth. In addition, the expression of the Flo11 N-terminal domains from C. lusitaniae (see above), S. paradoxus, Kluyveromyces lactis, Torulospora delbrueckii, and Komagataella pastoris were expressed and conferred also adhesive growth to S. cerevisiae, which indicates that the capacity of the Flo11 domains for conferring cellular adhesion is highly conserved in Saccharomycetales. C. intermedia is rarely reported as a human pathogen. Catheter-related fungemia caused by C. intermedia, which were treated successfully with fluconazole and catheter removal, have been reported [265] . Misidentification of C. duobushaemulonii (which is also a human pathogen) as C. intermedia has also been reported recently [266] . We found two Flo11-type adhesins in the Pfam database: one that contains only one Flo11 domain and one that contains six Flo11 domains in the N-terminal region of the protein as well as five flocculin type 3 repeats at the C-terminal region (Table 3) . These adhesions could play a role in catheter adhesion and biofilm formation. C. viswanathii was isolated from cerebrospinal fluid (CSF) of a fatal case of meningitis, and was reported as a new yeast species by Viswanathan and Randhawa in 1959 [267] . Later, the yeast was also found in routine sputum cultures and a detailed description of the fungus including the Latin diagnosis was provided, and its taxonomic nomenclature validated [268] . A recent study evaluating the pathogenicity for normal and cortisonetreated mice showed that C. viswanathii is an opportunistic pathogen [269] . Due to a lack of mycological expertise for comprehensive phenotypic characterization in a vast majority of laboratory diagnostic centres, the prevalence of C. viswanathii in clinical and environmental samples is currently likely underestimated. We identified one Flo11-type adhesin that contained only one Flo11 domain in the N-terminal region, in the Pfam database. C. fabianii (teleomorph Cyberlindnera fabianii) is an ascomycetous yeast of the Phaffomycetaceae family. It has been described under the genus Hansenula, Pichia and Lindnera [270] , and next as Cyberlindnera along with 20 other taxa since the genus Lindnera was a later homonym of an already published genus Lindnera in 1866 [271] . C. fabianii rarely been reported as a human pathogen, but due to advanced diagnostic methods and therapeutic techniques, infection has been increasingly recognised [272] [273] [274] [275] [276] [277] [278] [279] [280] [281] [282] [283] [284] [285] [286] [287] [288] . One Flo11-type adhesin that contains two Flo11 domains in the N-terminal region, was found in the Pfam database (Table 3) . C. haemulonii is a rare Candida subtype that is an emerging and virulent yeast pathogen. C. haemuloni infection have been wide spread, ranging from South America, Asia, the Middle East and Europe [289] . The first case report of C. haemulonii infection in the United States was in 1991 [289] , a second in 2020 [62] . Species identification is difficult due to phenotypic similarity to other Candida subtypes, such that there is a high risk of inappropriate antimicrobial administration and worsening of emerging resistance patterns. C. haemulonii has a proclivity for infection of chronic lower extremity wounds particularly in diabetic patients [62] . One Flo11-type adhesin that contains one Flo11 domains in the N-terminal region and collagen triple helix repeat, was found in the Pfam database (Table 3) . C. inconspicua was firstly described as Torulopsis inconspicua and later reclassified in Candida [290] . The species belongs to the Pichia cactophila clade, together with P. kudriavzevii (synonym C. krusei [291] ), Pichia norvegensis, P. cactophila, and Pichia pseudocactophila [292, 293] . C. inconspicua is genetically similar and phenotypically identical to P. cactophila and it has been suggested that they represent different sexual stages of the same species [270, 294] . Genome sequencing of the type strain (CBS180) and several clinical isolates uncovered the hybrid origin of C. inconspicua [292] . C. inconspicua is a an emerging pathogen responsible for infections that are more prominent in European countries [294] [295] [296] . Most of the infections are associated with osteomyelitis, oropharyngeal and esophageal candidiasis in HIV positive patients, as well as with candidemia in patients with hematological malignancies [295, 297, 298] . C. inconspicua showed a low susceptibility to fluconazole and other antifungals [291] [292] [293] [294] [295] [296] [297] [298] [299] [300] [301] . One Flo11-type adhesin that contains one Flo11 domains in the N-terminal region and three CMB_1 (Carbohydrate-binding module, fungal cellulose binding domain) domains, was found in the Pfam database (Table 3 ). In the protein architecture of hydrolytic enzymes that degrade polysaccharides, one or more non-catalytic CMBs are present besides the catalytic modules [302] [303] [304] . The CBMs have been shown to increase the proximity of the enzyme to its substrate, especially for insoluble substrates. P. kudriazvevii is widely distributed in the environment that is used in traditional food and beverage fermentations [305, 306] . P. kudriavzevii is exceptionally tolerant to stresses and, therefore, has been used to produce bioethanol [307, 308] , succinic acid [309] , and glycerol (under the name C. glycerinogenes) [310] . P. kudriazvevii can be pathogenic for humans. Recently, an outbreak of fungaemia in a neonatal intensive care unit due to P. kudriavzevii (a teleomorph of C. krusei) was reported [311] . P. kudriavzevii can adhere to intestinal cells although this is strongly strain dependent [312, 313] as well as to abiotic surfaces such as polystyrene and stainless-steel surfaces [166] . We found two Flo11-type adhesins in the Pfam database: one that contains only one Flo11 domain and one that contains a Flo11 domain in the N-terminal region of the protein as well as two CMB_1 domains (Table 3) . Wickerhamomyces anomalus is a heterothallic, ascomycetous yeast, forming one to four hat-shaped ascospores [314] . W. anomalus (synonym C. pelliculosa, formerly also known as Pichia anomala and Hansenula anomala) was recently assigned to the genus Wickerhamomyces based on phylogenetic analysis of gene sequences [315] . This species has a wide biotechnological potential [316] for its use in the fermentation of wines [317, 318] , as a biopreservation or biocontrol agent, and the production of biofuels and therapeutic molecules used in human medicine [319] [320] [321] . It shows a wide spectrum antimicrobial activity, being active against a variety of microorganisms including other yeasts, filamentous fungi and bacteria [316] . W. anomalus is a very rare pathogen causing blood stream infections in neonates [275, [322] [323] [324] [325] . It has been shown that W. anomalus can form biofilms on abiotic surfaces of a brewery plant [326] as well as on polystyrene and steel surfaces in vitro [166] . Lodderomyces elongisporus has been isolated from a variety of fruit concentrates, fresh fruits and soft drinks, wine [327] and insects [328] . It was considered as a teleomorph of C. parapsilosis, but 18S rRNA sequencing revealed that L. elongisporus represents a distinct species [329, 330] . Recently, it was identified in catheter-related bloodstream infections, where it was isolated from both blood and catheter tip cultures from patients [60, [331] [332] [333] [334] [335] [336] [337] . The adhesion of L. elongisporus to polystyrene and steel surfaces in vitro has been demonstrated [166] . We found one Flo11-type adhesin that contains one Flo11 domain in the N-terminal region of the protein as well as two flocculin type 3 repeats, in the Pfam database ( Table 3) . Hyphopichia burtonii is a yeast that is responsible for the spoilage of food bakery products, cookies and cured meat [338, 339] . It has been reported causing cutaneous infection in Barbastelle bats [340] . Recently, the first human infection caused by H. burtonii, resulting in peritonitis in a patient on peritoneal dialysis initially diagnosed as sterile peritonitis, resulting in delayed diagnosis and treatment [341] . We found one Flo11-type adhesin that contains one Flo11 domain in the N-terminal region of the protein as well as one flocculin type 3 repeats, in the Pfam database (Table 3) . Debaryomyces hansenii (Torulaspora hansenii) (teleomorph C. famata) is a hemiascomycetous marine yeast that is usually found in natural substrates and in various cheese due to its high tolerance to salt and growth at low temperatures [342] . It has also been detected in human infections [343] [344] [345] . However, C. guilliermondii and other Candida have been misidentified as D. hansenii/C. famata [346, 347] since they are extremely difficult to differentiate phenotypically [348, 349] . The adhesion of D. hansenii to intestinal cells has been demonstrated [312] . One Flo11-type adhesin that contains one Flo11 domains in the N-terminal region, was identified in the Pfam database (Table 3) . The Flo adhesins were first discovered in S. cerevisiae and S. pastorianus. They have been studied intensely, mainly due to their role during the beer fermentation process. S. cerevisiae and S. patorianus (Table 2) can be found in many natural environments including fruits, trees, and soil, and has been used for centuries for the production of beer [63, 350] , wine, and bread. S. cerevisiae is designated as a GRAS ("Generally Recognized as Safe") yeast. Despite its ubiquity and long association with humans, S. cerevisiae is rarely implicated as a causative agent of infections in healthy individuals. S. cerevisiae can be present in the skin, oral cavities, oropharynx, duodenal mucosa, digestive tract and vagina of healthy persons [351] [352] [353] . However, S. cerevisiae has been recognized as an emerging fungal pathogen for immunocompromised individuals in recent decades [354] . Since the 1990s [351] , there have been a growing number of reports about S. cerevisiae invasive infections, and novel strains continue to be developed [355, 356] . S. cerevisiae infections have been often associated with administration of probiotic S. cerevisiae var. boulardii strains or certain strains of S. cerevisiae [357] [358] [359] [360] [361] [362] [363] [364] [365] [366] (Table 2) . S. cerevisiae adhesion is the first step in the infection process. Adhesion can be on biotic or abiotic surfaces such as plastics, stainless steel or glass surfaces, which can lead to the development of biofilms [45, 129, 130] . The rise in systemic fungal infections does also coincide with the increasing use of implants such as plastic catheters, prosthetic heart valves, cardiac pacemakers, endotracheal tubes, dentures, and cerebrospinal fluid shunts [367, 368] . Access of fungi to the bloodstream and internal organs results from their ability to adhere to these prostheses, and next, to various surface receptors of host tissue cells. Prostheses can also serve as a carrier for fungal biofilms and thus provide an internal reservoir of highly resistant infective cells. It has been demonstrated that the adhesion to abiotic surfaces is mediated by Flo11p (Table 1 ) (see also Section 3.2) [69] . It is well known that microorganisms growing as biofilms are more resistant to various drugs and treatments than solitary cells and biofilms show an enhanced protection from host defences [369, 370] . The involvement of the lectin-type Flo proteins in the development of S. cerevisiae biofilms has not yet been described. Based on the binding mechanism of the lectin-type Flo proteins, i.e., binding to mannose containing glycans (i.e., mannose, Manα-1,2-Man, Manα-1,3-Man and Manα-1,6-Man glycan determinants), it can be hypothesized that S. cerevisiae cells expressing these flocculins could bind to cell receptors with high mannose N-glycans. S. boulardii (Table 2 ) is a probiotic yeast that is often used for the treatment of gastrointestinal (GI) tract disorders such as diarrhea symptoms or chronic diseases such as inflammatory bowel disease [365, 371, 372] . Even though S. boulardii is generally regarded as safe [373] , fungemia and sepsis are possible concerns, particularly in immunocompromised patients [371] . Rare occurrences of fungemia have been reported in people receiving therapeutic doses of S. boulardii or post-surgery [357, 358, 368, 374, 375] . These cases make it evident that S. boulardii fungemia is a distinct but rare possibility in patients with severely compromised health conditions, especially those involving the GI tract or the circulatory system [371] . S. boulardii and S. cerevisiae are genetically very similar, each containing 16 chromosomes with greater than 99% relatedness by average nucleotide identity [376] . One of the important differences include the genes expressing some flocculation proteins, which contribute to a different adhesion profile of S. boulardii when compared to S. cerevisiae [377] . Complete flocculin genes were identified in the whole genomes of S. boulardii where the repeats and their copies were varying even within S. boulardii genomes [376] . S. boulardii harbours the flocculin genes FLO1, FLO10 and FLO11 as well as the (nontruncated) FLO8 gene involved in the regulation of the expression of the FLO genes. These genes are located at telomeres and are highly repetitive, and the maximum number of repeats identified in the strains of S. boulardii could be conferring higher adhesive properties to the organism. Yeast adhesion proteins play a fundamental role in many processes where cell-cell or cell-substrate interactions are involved such as switching from a unicellular lifestyle to a multicellular one. They are also critical in pathogenic yeast-host interactions. The first step in the infection of fungal pathogens in humans is the adhesion of the pathogen to host tissue cells or abiotic surfaces such as catheters. One of the main players involved in this are the expressed cell wall adhesins. Here, we reviewed the Flo adhesins that could be involved in human yeast infections. The Flo adhesin family was originally subdivided into two subgroups. Based on the recent knowledge of the protein architecture of the Flo adhesins, we redefined these two subgroups into a PA/GLEYA Flo adhesin class and a Flo11-type class. These both classes are further subdivided according to the presence of 1 or more additional "Flo" domains. In this way, the PA14/GLEYA Flo adhesin class could be further subdivided into adhesins that besides a PA14 domain or GLEYA domain also contains a flocculin domain or/and a flocculin type 3 repeat domain. The Flo11-type adhesins could be further subdivided into architectures containing only the Flo11 domain, the Flo 11 domain and the flocculin domain or the flocculin type 3 repeat, and the Flo 11 domain and another adhesin structural domain. Pfam database mining based on this new definition of the Flo adhesin family, identified Flo adhesin architectures in many pathogenic yeasts such as several emerging non-albicans Candida species that are becoming a major threat to humans due to their resistance to antifungals and high mortality. In some cases, a critical role of the identified adhesin has been elucidated during recent research. However, in many cases the role of these adhesins in the infections process has still to be unravelled. For a detailed understanding of binding mechanism of these adhesins and to develop strategies to inhibit them, the atomic structure of the adhesins should be solved. Until now, the structures of only a few yeast adhesins involved in human infections have been solved (see also [86] ). Structural studies will have to be complemented with biophysical interaction studies on the molecular and cellular level. Global and multi-national prevalence of fungal diseases-Estimate precision Calling upon all public health mycologists: To accompany the country burden papers from 14 countries New pathogens, new tricks: Emerging, drug-resistant fungal pathogens and future prospects for antifungal therapeutics Changing patterns and trends in systemic fungal infections Obesity and the risk and outcome of infection The immune system in children with malnutrition-A systematic review Impact of childhood malnutrition on host defense and infection COVID-19 associated pulmonary aspergillosis Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 COVID-19-associated pulmonary aspergillosis Lass-Flörl, C.; Hoenigl, M. COVID-19 associated pulmonary aspergillosis (CAPA)-From immunology to treatment Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM/ISHAM consensus criteria for research and clinical guidance Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study Tackling human fungal infections Hidden killers: Human fungal infections Epidemiological trends in skin mycoses worldwide Vulvovaginal candidosis Epidemiology of invasive fungal infection Emerging opportunistic yeast infections Emerging systemic fungal infections Pharmacodynamics and Pharmacokinetics of Antifungals for Treatment of Invasive Aspergillosis Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment New horizons in antifungal therapy Drug-Drug Interactions of Triazole Antifungal Agents in Multimorbid Patients and Implications for Patient Care Current concepts in antifungal pharmacology Drugs currently under investigation for the treatment of invasive candidiasis. Expert Opin. Investig The antifungal pipeline: A reality check Antifungals discovery: An insight into new strategies to combat antifungal resistance New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species Current insights on antifungal therapy: Novel nanotechnology approaches for drug delivery systems and new drugs from natural sources The Future of Antifungal Drug Therapy: Novel Compounds and Targets Current and promising pharmacotherapeutic options for candidiasis Adhesins in Human Fungal Pathogens: Glue with Plenty of Stick The dominant flocculation genes of Saccharomyces cerevisiae constitute a new subtelomeric gene family A Saccharomyces gene family involved in invasive growth, cell-cell adhesion, and mating The ALS gene family of Candida albicans The Cell Surface Flocculin Flo11 Is Required for Pseudohyphae Formation and Invasion by Snf1 Kinases with Different β-Subunit Isoforms Play Distinct Roles in Regulating Haploid Invasive Growth Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins Bakers' yeast, a model for fungal biofilm formation Phenotypic diversity of Flo protein family-mediated adhesion in Saccharomyces cerevisiae An Adhesin of the Yeast Pathogen Candida glabrata Mediating Adherence to Human Epithelial Cells EAP1, a Candida albicans Gene Involved in Binding Human Epithelial Cells Glycan microarray analysis of Candida glabrata adhesin ligand specificity Genetic and epigenetic mechanisms underlying cell-surface variability in protozoa and fungi Flocculation protein structure and cell-cell adhesion mechanism in Saccharomyces cerevisiae The endothelial glycocalyx: Composition, functions, and visualization. Pflügers Arch.-Eur Role of glycosides as epithelial cell receptors for Candida albicans Fucose-specific adhesins on germ tubes of Candida albicans Lectin-glycan interaction network-based identification of host receptors of microbial pathogenic adhesins Nosocomial fungal infections: Epidemiology, diagnosis, and treatment Candida biofilms on implanted biomaterials: A clinically significant problem Biofilm formation on dental restorative and implant materials Are we any closer to beating the biofilm: Novel methods of biofilm control Epidemiology of candidiasis Epidemiology of invasive candidiasis: A persistent public health problem Twelve years of fluconazole in clinical practice: Global-trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida Antifungal susceptibility of emerging yeast pathogens Candida haemulonii: An emerging opportunistic pathogen in the United States? IDCases 2020, 21, e00900 Beverages: The Beer Brewing Process: Wort Production and Beer Fermentation Choosing the right lifestyle: Adhesion and development in Saccharomyces cerevisiae Unipolar cell divisions in the yeast S. cerevisiae lead to filamentous growth: Regulation by starvation and RAS Glucose depletion causes haploid invasive growth in yeast Multicellular microorganisms: Laboratory versus nature Yeast flocculation: Flo1 and NewFlo phenotypes and receptor structure Interactions by the fungal Flo11 adhesin depend on a fibronectin type III-like adhesin domain girdled by aromatic bands Pretorius, I.S. MUC1, a mucin-like protein that is regulated by MSS10, is critical for pseudohyphal differentiation in yeast Going with the flo: The role of flo11-dependent and independent interactions in yeast mat formation The role of FLO11 in Saccharomyces cerevisiae biofilm development in a laboratory based flow-cell system Saccharomyces cerevisiae-A model to uncover molecular mechanisms for yeast biofilm biology Expression and Characterization of the Flocculin Flo11/Muc1, a Saccharomyces cerevisiae Mannoprotein with Homotypic Properties of Adhesion The N-terminal domain of the Flo11 protein from Saccharomyces cerevisiae is an adhesin without mannose-binding activity Pheromone-regulated genes required for yeast mating differentiation The AGA1 product is involved in cell surface attachment of the Saccharomyces cerevisiae cell adhesion glycoprotein a-agglutinin Saccharomyces cerevisiae a-and alphaagglutinin: Characterization of their molecular interaction AG alpha 1 is the structural gene for the Saccharomyces cerevisiae alpha-agglutinin, a cell surface glycoprotein involved in cell-cell interactions during mating In silicio identification of glycosylphosphatidylinositol-anchored plansma-membrane and cell wall proteins of Saccharomyces cerevisiae Why are proteins O-glycosylated? Intragenic tandem repeats generate functional variability Genetic basis of flocculation phenotype conversion in Saccharomyces cerevisiae Flocculation causes inhibitor tolerance in Saccharomyces cerevisiae for second-generation bioethanol production Flocculation, adhesion and biofilm formation in yeasts Adhesins of yeasts: Protein structure and interactions The PA14 domain, a conserved all-β domain in bacterial toxins, enzymes, adhesins and signaling molecules Crystal structure of the anthrax toxin protective antigen Role of a PA14 domain in determining substrate specificity of a glycoside hydrolase family 3 β-glucosidase from Kluyveromyces marxianus NMR spectroscopic analysis reveals extensive binding interactions of complex xyloglucan oligosaccharides with the Cellvibrio japonicus glycoside hydrolase family 31 α-xylosidase Molecular phylogenetics of ascomycotal adhesins-A novel family of putative cell-surface adhesive proteins in fission yeasts The epithelial adhesin 1 (Epa1p) from the human-pathogenic yeast Candida glabrata: Structural and functional study of the carbohydrate-binding domain Molecular Mechanism of Flocculation Self-Recognition in Yeast and Modular domain structure in the Candida glabrata adhesin Epa1p, a β1,6 glucan-cross-linked cell wall protein Structural basis for promiscuity and specificity during Candida glabrata invasion of host epithelia Structural and biochemical characterization of the N-terminal domain of flocculin Lg-Flo1p from Saccharomyces pastorianusreveals a unique specificity for phosphorylated mannose Structural and Functional Characterization of PA14/Flo5-Like Adhesins From Komagataella pastoris Structural Hot Spots Determine Functional Diversity of the Candida glabrata Epithelial Adhesin Family Kin discrimination in social yeast is mediated by cell surface receptors of the flo11 adhesin family Structural basis of flocculin-mediated social behavior in yeast The N-terminal domain of the flo1 flocculation protein from Saccharomyces cerevisiae binds specifically to mannose carbohydrates Localization and Cell Surface Anchoring of the Saccharomyces cerevisiae Flocculation Protein Flo1p Carbohydrate-carbohydrate interactions in cell recognition Self-Recognition and Ca2+-Dependent Carbohydrate-Carbohydrate Cell Adhesion Provide Clues to the Cambrian Explosion Pathogens 2021 ConSurf: Identification of functional regions in proteins by surface-mapping of phylogenetic information The projection of evolutionary conservation scores of residues on protein structures Fluidic Force Microscopy Captures Amyloid Bonds between Microbial Cells Fluidic Force Microscopy Demonstrates That Homophilic Adhesion by Candida albicans Als Proteins Is Mediated by Amyloid Bonds between Cells A New Function for Amyloid-Like Interactions: Cross-Beta Aggregates of Adhesins form Cell-to-Cell Bonds Amyloid-Like β-Aggregates as Force-Sensitive Switches in Fungal Forces in yeast flocculation FLO11, a yeast gene related to the STA genes, encodes a novel cell surface flocculin MAP kinase and cAMP filamentation signaling pathways converge on the unusually large promoter of the yeast FLO11 gene Elements of a single map kinase cascade in Saccharomyces cerevisiae mediate two developmental programs in the same cell type: Mating and invasive growth Symmetric cell division in pseudohyphae of the yeast Saccharomyces cerevisiae Pseudohyphal development of Saccharomyces cerevisiae FLO11 mediated filamentous growth of the yeast Saccharomyces cerevisiae depends on the expression of the ribosomal RPS26 genes The signaling mucins Msb2 and Hkr1 differentially regulate the filamentation mitogen-activated protein kinase pathway and contribute to a multimodal response Mat formation in Saccharomyces cerevisiae requires nutrient and pH gradients The Wsc1p cell wall signaling protein controls biofilm (Mat) formation independently of Flo11p in Saccharomyces cerevisiae FLO11 is the primary factor in flor formation caused by cell surface hydrophobicity in wild-type flor yeast FLO11-Based Model for Air-Liquid Interfacial Biofilm Formation by Saccharomyces cerevisiae FLO11 is essential for flor formation caused by the C-terminal deletion of NRG1 in Saccharomyces cerevisiae Flor yeasts of Saccharomyces cerevisiae-Their ecology, genetics and metabolism The Flo11p-deficient Saccharomyces cerevisiae strain background S288c can adhere to plastic surfaces Identification of amino acids involved in the Flo11p-mediated adhesion of Saccharomyces cerevisiae to a polystyrene surface using phage display with competitive elution Characteristics of Flo11-dependent flocculation in Saccharomyces cerevisiae Flocculence of Saccharomyces cerevisiae cells is induced by nutrient limitation, with cell surface hydrophobicity as a major determinant Determinants of flocculence of brewer's yeast during fermentation in wort The importance of surface charge and hydrophobicity for the flocculation of chain-forming brewing yeast strains and resistance of these parameters to acid washing Molecular Basis for Strain Variation in the Saccharomyces cerevisiae Adhesin Flo11p The fibronectin type III domain as a scaffold for novel binding proteins Pathogens 2021 Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans A Lot More Than Meets the Eye. Microorganisms Adherence and biofilm formation of non-Candida albicans Candida species Two unlike cousins: Candida albicans and C.glabrata infection strategies A yeast by any other name: Candida glabrata and its interaction with the host From Saccharomyces cerevisiae to Candida glabrata in a few easy steps: Important adaptations for an opportunistic pathogen Candida bloodstream infections: Comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program Global trends in the distribution of Candida species causing candidemia Candida glabrata: Pathogenicity and Resistance Mechanisms for Adaptation and Survival The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcareassociated infections and antimicrobial use Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate Second-generation azole antifungal agents Changing epidemiology of systemic fungal infections Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients Complementary Adhesin Function in C. albicans Biofilm Formation Biofilms of non-Candida albicans Candida species: Quantification, structure and matrix composition Candida glabrata Biofilms: How Far Have We Come? A case of breakthrough Candida parapsilosis fungemia during micafungin therapy for a Candida glabrata bloodstream infection Adhesins in candida glabrata Candida biofilms and their role in infection Candida Infections of Medical Devices Candida biofilms: An update Biofilm formation by Candida species on intrauretheral catheter and its antifungal susceptibility profile Systematic identification in silico of covalently bound cell wall proteins and analysis of protein-polysaccharide linkages of the human pathogen Candida glabrata The Cell Wall of the Human Pathogen Candida glabrata: Differential Incorporation of Novel Adhesin-Like Wall Proteins Engineering the carbohydrate-binding site of Epa1p from Candida glabrata: Generation of adhesin mutants with different carbohydrate specificity Comparative genomics of emerging pathogens in the Candida glabrata clade Mycoses caused by Candida lusitaniae Disseminated Candida lusitaniae: Nosocomial Acquisition Secondary to an Indwelling Urinary Catheter. Case Rep Candida lusitaniae Breakthrough Fungemia in an Immuno-Compromised Adolescent: Case Report and Review of the Literature Candida lusitaniae Infections in the Era of Fluconazole Availability Adhesion Properties, Biofilm Forming Potential, and Susceptibility to Disinfectants of Contaminant Wine Yeasts Candida parapsilosis, an emerging fungal pathogen Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III Candidemia in a neonatal intensive care unit: Trends during fifteen years and clinical features of 111 cases In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods Analysis on clinical characteristics and drug resistance of Candida parapsilosis bloodstream infections in West China Hospital, China, from 2012 to 2015 Initial use of voriconazole positively affects outcome of Candida parapsilosis bloodstream infection: A retrospective analysis In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance Neonatal candidaemia in Kuwait: A 12-year study of risk factors, species spectrum and antifungal susceptibility Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients Epidemiology of Opportunistic Fungal Infections in Latin America Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from Candida parapsilosis candidaemia in a neonatal unit over 7 years: A case series study Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes dos Santos Pedroso, R. Candidemia by Candida parapsilosis in a neonatal intensive care unit: Human and environmental reservoirs, virulence factors, and antifungal susceptibility Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity Factors governing adherence of Candida species to plastic surfaces Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata The relationship between the cell length, adhesion to acrylic and relative cell surface hydrophobicity of Candida parapsilosis Ishida, I. Variation of colony morphology and chromosomal rearrangement in Candida tropicalis pK233 Antigenicity of Candida tropicalis strain cells cultured at 27 and 37 • C Candida tropicalis in human disease Epidemiology of Candida species infections in critically ill non-immunosuppressed patients Candiduria in critically ill patients admitted to intensive care medical units Investigation of the possible association between nosocomial candiduria and candidaemia Epidemiology of candidemia in Brazil: A nationwide sentinel surveillance of candidemia in eleven medical centers Prospective Observational Study of Candidemia in São Paulo, Brazil: Incidence Rate, Epidemiology, and Predictors of Mortality Biofilm formation in clinical Candida isolates and its association with virulence Candida colonisation as a source for candidaemia Prospective Multicenter Surveillance Study of Funguria in Hospitalized Patients Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from populationbased surveillance Risk Factors for Candida tropicalis Fungemia in Patients with Cancer Increasing incidence of candidemia: Results from a 20-year nationwide study in Iceland Candidemia due to Candida tropicalis: Clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals Evolution of pathogenicity and sexual reproduction in eight Candida genomes Fibronectin-, vitronectin-and laminin-binding proteins at the cell walls of Candida parapsilosis and Candida tropicalis pathogenic yeasts Agglutinin-Like Sequence (ALS) Genes in the Candida parapsilosis Species Complex: Blurring the Boundaries Between Gene Families That Encode Cell-Wall Proteins Role of the inducible adhesin CpAls7 in binding of Candida parapsilosis to the extracellular matrix under fluid shear Targeted gene disruption in Candida parapsilosis demonstrates a role for CPAR2_404800 in adhesion to a biotic surface and in a murine model of ascending urinary tract infection Association of different Candida species with catheter-related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm-forming capabilities Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital Candida auris: A worrisome, globally emerging pathogen Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options Candida auris: An emerging pathogen "incognito Candida auris: An emerging fungal pathogen Candida auris: Epidemiology, biology, antifungal resistance, and virulence Candida auris-The growing menace to global health Clade-specific chromosomal rearrangements and loss of subtelomeric adhesins in Candida auris Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities Nine Things Genomics Can Tell Us About Candida auris. Front Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris The emerging pathogen Candida auris: Growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection Multidrug-resistant candida haemulonii and C. auris Neurosurgical device-associated infections due to Candida auris-Three cases from a single tertiary center Transcriptome Assembly and Profiling of Candida auris Combined Antifungal Resistance and Biofilm Tolerance: The Global Threat of Candida auris Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast Conserved Role for Biofilm Matrix Polysaccharides in Candida auris Drug Resistance Crystal structure of the collagen triple helix model Collagen Structure: The Madras Triple Helix and the Current Scenario Candida auris isolates of the southern asian and south african lineages exhibit different phenotypic and antifungal susceptibility profiles in vitro In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris Biofilm formation by Candida auris isolated from colonising sites and candidemia cases Experimental Mouse Models of Disseminated Candida auris Infection What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast Yeasts Pathogenic to Humans Phylogenetic analysis of ascomycete yeasts that form coenzyme Q-9 and the proposal of the new genera Babjeviella, Meyerozyma, Millerozyma, Priceomyces, and Scheffersomyces Two new species in the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb Multiple gene genealogical analyses suggest divergence and recent clonal dispersal in the opportunistic human pathogen Candida guilliermondii Identification and susceptibility profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates Biotechnological applications of the non-conventional yeast Meyerozyma guilliermondii Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: Geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program Epidemiology and outcomes of candidemia in 3648 patients: Data from the Prospective Antifungal Therapy (PATH Alliance ® ) registry Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10 Candida colonization in intensive care unit patients' urine Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: An experience in a tertiary hospital in mid-Taiwan Clinical Characteristics and Outcomes of Candidemia Caused by Meyerozyma guilliermondii Complex in Cancer Patients Undergoing Surgery Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in Candida guilliermondii: Biotechnological applications, perspectives for biological control, emerging clinical importance and recent advances in genetics Identification and antifungal susceptibility profile of candida guilliermondii and candida fermentati from a multicenter study in China Clinical and microbiological characteristics of candida guilliermondii and candida fermentati Candidemia due to candida guilliermondii in an immunocompromised infant: A case report and review of literature Osteomyelitis caused by high resistant Candida guilliermondii Non-albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance Candida guilliermondii fungemia in patients with hematologic malignancies Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period Recent experience with fungaemia: Change in species distribution and azole resistance Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: Results from a surveillance study on fungaemia in Germany from Effects of caspofungin against Candida guilliermondii and Candida parapsilosis Pan-azole-Resistant Candida guilliermondii from a Leukemia Patient's Silent Funguria Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia Catheter-related fungemia caused by Candida intermedia Isolation of candida viswanathii from cerebrospinal fluid Pathogenicity of Candida viswanathii for normal and cortisone-treated mice Phylogenetic relationships among species of Pichia, Issatchenkia and Williopsis determined from multigene sequence analysis, and the proposal of Barnettozyma gen. nov., Lindnera gen. nov. and Wickerhamomyces gen Prostatitis Caused by Hansenula fabianii Infection in a neonate caused by Pichia fabianii: Importance of molecular identification Cyberlindnera (Pichia) fabianii infection in a neutropenic child: Importance of molecular identification Pichia fabianii fungemia in a neonate Pichia fabianii blood infection in a premature infant in China: Case report SEIMC) and Fungemia due to rare opportunistic yeasts: Data from a population-based surveillance in Spain Peritonitis in a neonate due to Cyberlindnera fabianii, an ascomycetic yeast Fatal Cyberlindnera fabianii fungemia in a patient with mixed phenotype acute leukemia after umbilical cord blood transplantation Multiple organ dysfunction syndrome and death secondary to Cyberlindnera fabianii Identification of Candida fabianii as a cause of lethal septicaemia A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment Catheter-related bloodstream infection by Lindnera fabianii in a neutropenic patient Lindnera (Pichia) fabianii blood infection after mesenteric ischemia Cyberlindnera fabianii fungaemia outbreak in preterm neonates in Kuwait and literature review Successful Treatment of Fungemia Caused by Cyberlindnera fabianii with Anidulafungin: A Case Report Cyberlindnera fabianii in the neonatal and paediatric intensive care unit: Case reports First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianii. Case Rep Candida haemulonii species complex: An emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses Proposal for amendment of the diagnosis of the genus Candida Berkhout nom. cons Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names Whole-genome sequencing of the opportunistic yeast pathogen candida inconspicua uncovers its hybrid origin New insights into identification in relation to sexual reproduction and genome organization Invasive infections due to Candida norvegensis and Candida inconspicua: Report of 12 cases and review of the literature Fluconazole susceptibility testing of Candida inconspicua clinical isolates: Comparison of four methods Results from the artemis disk global antifungal surveillance study, 1997 to 2007: A 10.5-year analysis of susceptibilities of candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies Candida inconspicua, a Fluconazole-Resistant Pathogen in Patients Infected with Human Immunodeficiency Virus Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined by the time-kill method Antifungal susceptibility profiles of rare ascomycetous yeasts Carbohydrate-binding modules: Fine-tuning polysaccharide recognition Rodríguez-Sanoja, R. Carbohydrate-binding domains: Multiplicity of biological roles Carbohydrate Binding Modules: Diversity of Domain Architecture in Amylases and Cellulases From Filamentous Microorganisms Analyzing the relation between the microbial diversity of DaQu and the turbidity spoilage of traditional Chinese vinegar Food fermentations: Microorganisms with technological beneficial use Looking beyond Saccharomyces: The potential of non-conventional yeast species for desirable traits in bioethanol fermentation Phenotypic landscape of non-conventional yeast species for different stress tolerance traits desirable in bioethanol fermentation Exploiting Issatchenkia orientalis SD108 for succinic acid production Glycerol production by microbial fermentation: A review Outbreak of Pichia kudriavzevii fungaemia in a neonatal intensive care unit Screening of Dairy Yeast Strains for Probiotic Applications Potential probiotic Pichia kudriavzevii strains and their ability to enhance folate content of traditional cereal-based African fermented food Biotechnology, physiology and genetics of the yeast Pichia anomala Microbial resources and enological significance: Opportunities and benefits Pichia anomala: Cell physiology and biotechnology relative to other yeasts Wickerhamomyces anomalus AS1: A new strain with potential to improve wine aroma Challenges of the Non-Conventional Yeast Wickerhamomyces anomalus in Winemaking A Wickerhamomyces anomalus Killer Strain in the Malaria Vector Anopheles stephensi Efficacy of Wickerhamomyces anomalus yeast in the biocontrol of blue mold decay in apples and investigation of the mechanisms involved Investigating the biocontrol potentiality of Wickerhamomyces anomalus against postharvest gray mold decay in cherry tomatoes Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit Wickerhamomyces anomalus blood stream infection in a term newborn with pneumonia Rare Invasive Yeast Infections in Greek Neonates and Children, a Retrospective 12-Year Study Microbial attachment and biofilm formation in brewery bottling plants Belda, I. Occurrence and enological properties of two new non-conventional yeasts (Nakazawaea ishiwadae and Lodderomyces elongisporus) in wine fermentations Four novel Candida species in the Candida albicans/Lodderomyces elongisporus clade isolated from the gut of flower beetles Global analysis of protein localization in budding yeast The genetic relationship of Lodderomyces elongisporus to other ascomycete yeast species as revealed by small-subunit rRNA gene sequences Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections Isolation of lodderomyces elongisporus from the catheter tip of a fungemia patient in the Middle East. Case Rep Catheter-Related Bloodstream Infection Due to Lodderomyces elongisporus Lodderomyces elongisporus: A bloodstream pathogen of greater clinical significance Catheter-related Bloodstream Infection due to Lodderomyces elongisporus in a Patient with Lung Cancer Concurrent bloodstream infection with Lodderomyces elongisporus and Candida parapsilosis The brief case: A case of prosthetic valve endocarditis due to lodderomyces elongisporus Microflora of banh men, a fermentation starter from Vietnam Dynamics and characterization of yeasts during ripening of typical Italian dry-cured ham Cutaneous mycosis in a Barbastelle bat (Barbastella barbastellus) caused by Hyphopichia burtonii The first human report of Hyphopichia burtonii, initially misdiagnosed as sterile peritonitis in a patient on peritoneal dialysis PCR-RFLP analysis of the IGS region of rDNA: A useful tool for the practical discrimination between species of the genus Debaryomyces Fatal Candida famata peritonitis complicating sclerosing peritonitis in a peritoneal dialysis patient Torulopsis candida, a new opportunistic pathogen Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis Candida guilliermondii and other species of Candida misidentified as Candida famata: Assessment by Vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs Misidentification of Candida guilliermondii as C. Famata among strains isolated from blood cultures by the VITEK 2 system Differentiation between Debaryomyces hansenii/Candida famata complex and Candida guilliermondii by polymerase chain reaction Taxonomic position of clinical isolates of Candida famata Saccharomyces pastorianus: Genomic insights inspiring innovation for industry Invasive infection with Saccharomyces cerevisiae: Report of three cases and review Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates Vaginitis Due to Saccharomyces cerevisiae: Epidemiology, Clinical Aspects, and Therapy Opportunistic strains of Saccharomyces cerevisiae: A potential risk sold in food products Invasive Saccharomyces Infection: A Comprehensive Review Review of current methods for characterizing virulence and pathogenicity potential of industrial Saccharomyces cerevisiae strains towards humans Seven cases of fungemia with Saccharomyces boulardii in critically ill patients Outbreak of Saccharomyces cerevisiae Subtype boulardii Fungemia in Patients Neighboring Those Treated with a Probiotic Preparation of the Organism Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed acute myeloid leukaemia Saccharomyces cerevisiae osteomyelitis in an immunocompetent baker Epidemiology of invasive mycoses in North America Saccharomyces cerevisiae oesophagitis in a patient with oesophageal carcinoma Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient Origins of variation in the fungal cell surface Possible role of catheters in Saccharomyces boulardii fungemia Biofilms: Survival mechanisms of clinically relevant microorganisms Yeasts as probiotics: Mechanisms, outcomes, and future potential Saccharomyces boulardii: What Makes It Tick as Successful Probiotic? Review article: Yeast as probiotics-Saccharomyces boulardii Saccharomyces boulardii fungemia caused by treatment with a probioticum Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae